10 hasil untuk "Yu-Hsi Lin"
Menampilkan 1–10 · 1,43 detik · RSS
-
Artikel Jurnal Teks lengkap
ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase
Inhibition of glycolysis is of great potential for the treatment of cancer. However, inhibitors of glycolytic enzymes with favorable pharmacological profiles have not been forthcoming. Due to the nature of their active sites, most high-affinity transition-state analogue inhibitors of glycolysis…
Juga tersedia di: DOAJ
-
Artikel Jurnal
Introduction and Application of a Simple Probabilistic Liquefaction Hazard Analysis Program: HAZ45PL Module
The 2016 Meinong Earthquake hit southern Taiwan and many shallow foundation structures were damaged due to soil liquefaction. In response, the government initiated an investigation project to construct liquefaction potential maps for metropolitans in Taiwan. These maps were used for the preliminary…
-
Artikel Jurnal
Benchmarking multiple sequence alignment tools for SARS-CoV-2 genome and spike data
Introduction: One of the first steps in analyzing viral nucleotide/protein sequences is multiple sequence alignment (MSA). Due to the global effort of rapid diagnosis and advancement of sequencing technologies, more than three million SARS-CoV-2 genomes have been sequenced. This has given us an…
-
Artikel Jurnal Teks lengkap
The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues
We recently reported that SF2312 ((1,5-dihydroxy-2-oxopyrrolidin-3-yl)phosphonic acid), a phosphonate antibiotic with a previously unknown mode of action, is a potent inhibitor of the glycolytic enzyme, Enolase. SF2312 can only be synthesized as a racemic-diastereomeric mixture. However, co-crystal…
-
Artikel Jurnal Teks lengkap
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
-
Artikel Jurnal
Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma
Abstract Background Reprogramming of metabolic pathways is crucial to satisfy the bioenergetic and biosynthetic demands and maintain the redox status of rapidly proliferating cancer cells. In tumors, the tricarboxylic acid (TCA) cycle generates biosynthetic intermediates and must be replenished…
-
Artikel Jurnal
Targeting Host Glycolysis as a Strategy for Antimalarial Development
Glycolysis controls cellular energy, redox balance, and biosynthesis. Antiglycolytic therapies are under investigation for treatment of obesity, cancer, aging, autoimmunity, and microbial diseases. Interrupting glycolysis is highly valued as a therapeutic strategy, because glycolytic disruption is…
-
Artikel Jurnal
Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine
The metabolite methylthioadenosine (MTA) inhibits PRMT5. Therefore, MTA accumulation due to MTA phosphorylase (MTAP) deletion has been proposed as a vulnerability for PRMT5-targeted therapy in cancer. Here, the authors show that MTA does not accumulate in MTAP-deficient cancer cells but is secreted…
-
Artikel Jurnal
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma
Summary: Histone methyltransferase KMT2D harbors frequent loss-of-function somatic point mutations in several tumor types, including melanoma. Here, we identify KMT2D as a potent tumor suppressor in melanoma through an in vivo epigenome-focused pooled RNAi screen and confirm the finding by using a…